A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) ...

Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and other signs of low blood sugar (hypoglycemia). Insulin dosing is a multistep process that often requires careful ...

Highlights from last week include President Trump's executive orders, the FDA approval of esketamine nasal spray for depression ... epoetin alfa, and insulin glargine biosimilars have grown ...

If your ability to connect with others feels a little rusty post-pandemic, adding “social fitness” to your workout routine ...

In CHI, the beta cells in the pancreas do not function properly and secrete too much insulin, leading to frequent ... Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar ...

72 hr Manufacturer Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi ...

Feb. 5, 2025 — New research shows that women who hit menopause later in life have healthier blood vessels and mitochondria and a different composition of ... Drinking Ketones Improves Heart ...